Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant path...

por Song, Jae-Hoon, Oh, Won Sup, Kang, Cheol-In, Chung, Doo Ryeon, Peck, Kyong Ran, Ko, Kwan Soo, Yeom, Joon Sup, Kim, Choon Kwan, Kim, Shin Woo, Chang, Hyun-Ha, Kim, Yeon-Sook, Jung, Sook-In, Tong, Zhaohui, Wang, Qingtao, Huang, Shao-Guang, Liu, Jien-Wei, Lalitha, M.K., Tan, Ban-Hock, Van, Pham Hung, Carlos, Celia C., So, Thomas
Publicado 2008

Speaker presentations

Publicado 2017

Poster presentations

Publicado 2017

Emerging zoonoses: responsible communication with the media—lessons learned and future perspectives

por Tabbaa, D.
Publicado 2010

Arguments in favour of remdesivir for treating SARS-CoV-2 infections

por Ko, Wen-Chien, Rolain, Jean-Marc, Lee, Nan-Yao, Chen, Po-Lin, Huang, Ching-Tai, Lee, Ping-Ing, Hsueh, Po-Ren
Publicado 2020

Antibiotic resistance amongst healthcare-associated pathogens in China

por Yezli, Saber, Li, Han
Publicado 2012

Alice's living croquet theory

por Raoult, Didier
Publicado 2016

The epidemiology, diagnosis and treatment of COVID-19

por Zhai, Pan, Ding, Yanbing, Wu, Xia, Long, Junke, Zhong, Yanjun, Li, Yiming
Publicado 2020

Coronavirus disease 2019 (COVID-19): current status and future perspectives

por Li, Heng, Liu, Shang-Ming, Yu, Xiao-Hua, Tang, Shi-Lin, Tang, Chao-Ke
Publicado 2020

Coronavirus disease 2019 (COVID-19): first indication of efficacy of Gene-Eden-VIR/Novirin in SARS-CoV-2 infection

por Polansky, Hanan, Lori, Gillad
Publicado 2020

Chloroquine as a prophylactic agent against COVID-19?

por Gendrot, Mathieu, Javelle, Emilie, Clerc, Axelle, Savini, Hélène, Pradines, Bruno
Publicado 2020

Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine

por Sahraei, Zahra, Shabani, Minoosh, Shokouhi, Shervin, Saffaei, Ali
Publicado 2020

Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence

por Wang, Lisheng, Wang, Yiru, Ye, Dawei, Liu, Qingquan
Publicado 2020

Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies

por Zhao, Ming
Publicado 2020

Can post-exposure prophylaxis for COVID-19 be considered as an outbreak response strategy in long-term care hospitals?

por Lee, Sun Hee, Son, Hyunjin, Peck, Kyong Ran
Publicado 2020

Combating devastating COVID-19 by drug repurposing

por Pawar, Ashish Yashwantrao
Publicado 2020

Pharmacological perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19

por Luo, Pan, Liu, Dong, Li, Juan
Publicado 2020

Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein

por Vankadari, Naveen
Publicado 2020

Global coronavirus disease 2019: What has daily cumulative index taught us?

por Lai, Chih-Cheng, Wang, Cheng-Yi, Wang, Ya-Hui, Hsueh, Po-Ren
Publicado 2020

May drug-related cardiovascular toxicities persist after hospital discharge in COVID-19 patients?

por Kara, Emre, Inkaya, Ahmet Cagkan, Demirkan, Kutay
Publicado 2020